RxDoctor Payments Data

Howard Kaufman

Surgery · Pasadena, CANPI 1912939604

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $55,159 of the $78,970 with a category attached, or 69.8%. 24 manufacturers reported payments, led by Merck at 37.9% of the total. Reporting peaked in 2019 at $43,691 and has fallen 100.0% since, to $16 in 2025. Among surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,970in general payments, 2019–2025

Across 175 payments — averaging $451.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$30K
  • Medtronic$14K
  • Mallinckrodt Enterprises LLC$11K
  • Pacira Pharmaceuticals Incorporated$10K
  • Covidien LP$9K
  • Tetraphase Pharmaceuticals, Inc.$3K
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$8,36011%
  • Speaking & faculty fees$55,15970%
  • Travel & lodging$7,51910%
  • Food & beverage$7,90810%
  • Education$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,970 in reported general payments places this provider in the 95th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Other surgery in Pasadena

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →